The Legacy of Innovation: A Comprehensive Review of Eponymous Procedures in Thoracic, Congenital, and Pediatric Heart Diseases.

Eponymous cardiovascular surgeries have played an important role in the evolution of congenital and pediatric heart disease management. These procedures, named after pioneering surgeons, have significantly advanced surgical interventions for complex cardiac conditions. This review provides an overview of eponymous cardiovascular surgeries and their impact on managing congenital and pediatric heart diseases. We examine these procedures' historical significance, technical advancements, and evolving role in contemporary surgical practice. Historically, operations such as the Blalock-Taussig-Thomas shunt and the Fontan procedure have provided life-saving solutions for patients with congenital heart defects. Over time, many eponymous procedures have been refined or replaced as surgical techniques and technologies have evolved. For example, the Jatene procedure has largely supplanted the Mustard and Senning operations to transpose the great arteries, offering superior long-term outcomes. Similarly, in conditions of functional or anatomical absence of one ventricle, iterative improvements in the Fontan and Glenn procedures have enhanced survival rates and reduced complications. The advent of catheter-based interventions, hybrid surgical techniques, and three-dimensional imaging has further transformed the field, improving surgical precision and patient outcomes. Despite modifications and replacements, the legacy of these eponymous procedures remains foundational to cardiovascular surgery. Continued innovation, collaboration, and research will build upon these historical milestones, ensuring ongoing advancements in treating congenital and pediatric heart diseases.